Concepedia

Author

Glenn Ishioka

Cytel (United States)

Also Known As

Alexander, Jeff, G Ishioka, G Y Ishioka, G. Ishioka, G. Y. Ishioka, Glenn Ishioka, Glenn Y Ishioka, Glenn Y. Ishioka

47

Publications

2.8K

Citations

26

H-Index

38

Concepts

All Affiliations

Cytel (United States)PaxVax (United States)Epic Sciences (United States)PAX Scientific (United States)La Jolla Institute for Immunology
GI

About

Glenn Ishioka is an author at Cytel (United States) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

776

2

Immunology

12

12

776

3

Allergy

8

8

493

4

Cell Biology

4

4

411

5

Pathology

1

1

13

Glenn Ishioka

×

31

Publications

2.4K

Citations

25

H-Index

YearCitations

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

Antonella Vitiello, Glenn Ishioka, H M Grey,

Journal of Clinical Investigation

1995

334

cDNA cloning and immunological characterization of the rye grass allergen Lol p I.

Mary Perez, Glenn Ishioka, L E Walker,

Journal of Biological Chemistry

1990

174

MHC interaction and T cell recognition of carbohydrates and glycopeptides

Glenn Ishioka, Alan Lamont, David Thomson,

The Journal of Immunology

1992

168

Utilization of MHC Class I Transgenic Mice for Development of Minigene DNA Vaccines Encoding Multiple HLA-Restricted CTL Epitopes

Glenn Ishioka, John Fikes, Gary Hermanson,

The Journal of Immunology

1999

163

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

Marc Gurwith, Michael Lock, Eve M. Taylor,

The Lancet Infectious Diseases

2013

154

Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide

Shabnam Tangri, Glenn Ishioka, XIU‐QING HUANG,

The Journal of Experimental Medicine

2001

145

The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection

Brian Livingston, Claire Crimi, H M Grey,

The Journal of Immunology

1997

137

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis

Alessandra Franco, Scott Southwood, Thomas Arrhenius,

European Journal of Immunology

1994

122

Induction of Immune Responses and Clinical Efficacy in a Phase II Trial of IDM-2101, a 10-Epitope Cytotoxic T-Lymphocyte Vaccine, in Metastatic Non–Small-Cell Lung Cancer

Minal Barve, James Bender, Neil Senzer,

Journal of Clinical Oncology

2008

98

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.

Lupe G. Salazar, John Fikes, Scott Southwood,

PubMed

2003

97

Page 1